Morgan Stanley Raises Axon Enterprise (NASDAQ:AXON) Price Target to $310.00

Axon Enterprise (NASDAQ:AXON) had its price objective boosted by Morgan Stanley from $285.00 to $310.00 in a research note published on Friday, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock.

AXON has been the subject of a number of other research reports. William Blair reaffirmed an outperform rating on shares of Axon Enterprise in a research report on Wednesday, April 24th. TheStreet downgraded Axon Enterprise from a b rating to a c+ rating in a research report on Tuesday, February 27th. Needham & Company LLC reissued a buy rating and set a $400.00 price target on shares of Axon Enterprise in a research report on Wednesday, April 24th. JPMorgan Chase & Co. boosted their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an overweight rating in a research report on Thursday, April 11th. Finally, JMP Securities increased their price objective on Axon Enterprise from $250.00 to $285.00 and gave the company a market outperform rating in a report on Tuesday, February 6th. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of Moderate Buy and an average price target of $314.91.

Axon Enterprise Stock Performance

AXON opened at $313.30 on Friday. The company has a market capitalization of $23.64 billion, a price-to-earnings ratio of 136.22 and a beta of 0.93. The business’s 50-day moving average price is $305.09 and its two-hundred day moving average price is $262.90. Axon Enterprise has a 1 year low of $175.37 and a 1 year high of $329.87. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analysts’ expectations of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. Equities analysts expect that Axon Enterprise will post 2.44 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Commonwealth Equity Services LLC increased its holdings in shares of Axon Enterprise by 51.0% in the first quarter. Commonwealth Equity Services LLC now owns 60,756 shares of the biotechnology company’s stock valued at $19,010,000 after purchasing an additional 20,529 shares during the last quarter. Greenleaf Trust boosted its holdings in shares of Axon Enterprise by 5.8% during the 1st quarter. Greenleaf Trust now owns 1,647 shares of the biotechnology company’s stock worth $515,000 after buying an additional 91 shares during the period. Principal Financial Group Inc. grew its stake in Axon Enterprise by 4.1% in the 1st quarter. Principal Financial Group Inc. now owns 103,608 shares of the biotechnology company’s stock valued at $32,417,000 after buying an additional 4,052 shares during the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI raised its holdings in Axon Enterprise by 0.4% in the 1st quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 16,096 shares of the biotechnology company’s stock valued at $5,036,000 after acquiring an additional 68 shares during the period. Finally, Planned Solutions Inc. acquired a new stake in Axon Enterprise during the first quarter worth approximately $366,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.